AbbVie (ABBV): New Data Show RINVOQ Demonstrated Superiority Versus DUPIXENT Across Primary and All Secondary Endpoints

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. WBD
4. AMC
5. MSFT
6. AMZN
7. ACN
8. FFAI
9. PAA
10. TLT

Go back to AbbVie (ABBV): New Data Show RINVOQ Demonstrated Superiority Versus DUPIXENT Across Primary and All Secondary Endpoints
AbbVie (NYSE: ABBV) Delayed: 265.29 +1.33 (0.50%)
Previous Close $263.96    52 Week High $68.12 
Open $263.07    52 Week Low $50.71 
Day High $266.60    P/E 57.55 
Day Low $261.23    EPS $4.61 
Volume 654,025